Search

everythinglearnresearchcommunity

for

Search:↓

Recognizing trichoscopic features is crucial for diagnosing various hair loss conditions.

Trichoscopy effectively differentiates Androgenetic Alopecia from Telogen Effluvium.

The study concludes that traction alopecia, caused by hair styling, can help understand telogen effluvium, a condition of excessive hair loss.

Telogen Effluvium (TE) significantly affects women due to stress and hormonal changes, requiring better public health policies and mental health support.

Targeted testing for telogen effluvium patients can save healthcare costs.

Many people experience hair loss after COVID-19 infection.

Tufted folliculitis is common in patients with folliculitis decalvans.

A woman experienced fluctuating thyroid conditions and eye disease, but her symptoms improved with treatment.

The document concludes that we need more research to understand Telogen Effluvium and find effective treatments.

Trichoscopy is not specific for diagnosing telogen effluvium and both telogen effluvium and androgenetic alopecia often occur together.

A child on life support experienced rapid hair loss due to severe illness affecting hair growth.

Hair loss can be caused by stress, infections, drugs, and various diseases, with treatment depending on accurate diagnosis.

A fungal infection in the neck caused severe breathing issues, treated successfully with antibiotics and antifungal medication.

Taking fluconazole for fungal infections might cause hair loss after about 3 months.

Chronic telogen effluvium may not be a unique condition and could be confused with other types of hair loss.

A standardized guideline would improve Telogen Effluvium management.

COVID-19 may cause hair loss due to infection stress or treatments.

Thyroid autoimmunity may be involved in some female hair loss, suggesting the need to test for thyroid antibodies in these patients.

COVID-19 often causes hair loss, especially in women.

Half of the patients treated with a specific drug for skin cancer experienced hair loss not related to the drug's dosage.

Most Iraqi women with telogen effluvium did not have a clear cause for their hair loss, and few had significant thinning.

Most Iraqi women with telogen effluvium had no clear cause for their hair loss, and few had significant thinning.

The herbal drug worked faster than Minoxidil for treating telogen effluvium.

COVID-19 may cause temporary hair loss due to the body's immune response.

Thyroid dysfunction, vitamin D and B12 deficiencies, and iron deficiency may be linked to hair loss condition Telogen Effluvium.

Low levels of ferritin and vitamin B12 are common in women with telogen effluvium, but the link between nutrient deficiencies and the condition is not clear.

Telogen effluvium is common after symptomatic COVID-19, especially in young females, and may be linked to nutritional deficiencies.

Teprotumumab for thyroid eye disease commonly causes fatigue, brittle nails, dry eyes, hair loss, muscle spasms, and dry mouth, with rare serious events like blood clots.

Stopping azathioprine led to full hair regrowth and recovery in 2.5 months.

COVID-19 can cause hair loss in both severe and mild cases, often affecting women.